Mounjaro® 2.5 mg Weight Management Pen
Mounjaro® Weight Management Pen is a once-weekly injectable medication used as part of a medically guided weight management programme.
Its active ingredient, tirzepatide, is a dual agonist that acts on both GIP (glucose-dependent insulinotropic polypeptide) receptors and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism may help support weight management, improve insulin sensitivity and regulate metabolic responses.
Mounjaro® has been approved by the US FDA for the treatment of adults with type 2 diabetes. Clinical studies have also shown its potential role in supporting weight management when used together with appropriate lifestyle measures, making it one of the medical options that may be considered under professional supervision.
This programme requires an appointment with a doctor for consultation and assessment to determine whether the medication is suitable for you.
- The medication must be used under the guidance of a qualified healthcare professional
- The medication must be prescribed by a doctor
- If required, a nurse may assist with the first injection
- One-to-one registered dietitian consultation is also available to support your weight management plan*


















